• About
  • Editorial Board
    • Staff Writers
  • Advertise
  • Join Us
  • Archives
The Wellesley News -
  • News and Features
    • Professor Phillip Levine Discusses “A Problem of Fit”
      Professor Phillip Levine Discusses “A Problem of Fit”
    • CS Department shifts CS 111 course structure
      CS Department shifts CS 111 course structure
    • WAMI and WRJ host discussion on criminalization of abortion
      WAMI and WRJ host discussion on criminalization of abortion
    • News
      • News in Brief
      • Nation & World
      • President’s Corner
      • Senate Report
    • Features
      • Alumnae Spotlight
      • Eye on Science
      • Faculty Focus
      • LGBTQIA+ Column
  • Opinions
    • Why Art Basel is partially responsible for Miami’s gentrification
      Why Art Basel is partially responsible for Miami’s gentrification
    • It’s time to put traditional grading to the test
      It’s time to put traditional grading to the test
    • What can the fall of Z-library teach us about textbook accessibility?
      What can the fall of Z-library teach us about textbook accessibility?
    • Staff Editorial
    • Letters to the Editor
    • The Elephant in the Room
  • Arts
    • No image
      Pentimento’s Open Mic is Like an Old Patchwork Quilt–Worn, Yet Cozy
    • No image
      Kanye’s Antisemitism Steps on his Shoe Brand
    • Lousy Realities: Luca Guadagnino (2015)
      Lousy Realities: Luca Guadagnino (2015)
    • Arts In The News
    • Reviews
    • Music Peek
    • Books Before Boys
  • Sports and Wellness
    • Student-Athlete of October
      Student-Athlete of October
    • Athletics Update Oct. 19, 2022
      Athletics Update Oct. 19, 2022
    • The Case for Body Neutrality
      The Case for Body Neutrality
    • Athlete of the Week
    • Boston Sports Update
    • The Vegan Digest
    • The SHE Corner
  • The Wellesley Snooze
    • Top 10 Girlbosses who aren’t alumnae, but I would totally believe you if you told me they were
      Top 10 Girlbosses who aren’t alumnae, but I would totally believe you if you told me they were
    • Wendy Wellesley’s Thanksgiving Menu
      Wendy Wellesley’s Thanksgiving Menu
    • The Snooze Awards for the Best Tanners of 2022
      The Snooze Awards for the Best Tanners of 2022
  • Miscellanea
    • President’s Column: The Butterfly Effect
      President’s Column: The Butterfly Effect
    • Administrators shocked to learn that students dislike being left in dark
      Administrators shocked to learn that students dislike being left in dark
    • 50 Lies You Tell Yourself in Order to Survive Until Graduation
      50 Lies You Tell Yourself in Order to Survive Until Graduation
    • The Dose
    • The Olive Branch
    • Multimedia
      • Galleries
      • Infographics
      • Videos
By Alyssa Li Eye on Science, Features, News and FeaturesApril 3, 2019

HIV remission reported in bone marrow transplant patient in the United Kingdom

HIV infects and destroys T-cells Photo Courtesy of ReachMD

We often speak admirably about the human spirit — resilience, passion, resolve — and shy away from our fragility and mortality, especially when it concerns viruses. After all, what could be more terrifying than the idea that our bodies are deteriorating because of something unseen? And what could be worse than knowing there was no way to get better?

Such was the reality for patients afflicted with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), a chronic, life-threatening condition that previously was a death sentence. And while HIV/AIDS patients languished physically, they also suffered emotionally, facing social isolation and scrutiny. Indeed, few other diseases carry as much cultural significance as HIV; homosexual, African-American and immigrant patients faced unprecedented levels of discrimination during the 1970s and 80s. Today, patients continue to face the stigma associated with HIV despite effective noncurative treatments and prophylactic agents.

Biologically, HIV is a single-stranded, positive-sense ribonucleic acid retrovirus that causes AIDS. HIV preferentially infects and kills the body’s immune cells, including helper T cells, which help to mediate the body’s ability to respond to infections. When the body loses these critical cells, patients become more susceptible to the types of viral, bacterial, and fungal infections that healthy people do not normally get sick from. This pathobiology raises two questions: how does HIV infect these cells? And why are only immune cells affected?

HIV exhibits a unique tropism, a preference for infecting certain cells in the body. This tendency is caused by special proteins on the surface of HIV particle, called envelope glycoprotein 120 (gp120), which interacts with proteins on the surface of helper T cells, including CD4. You can think of gp120 as a key that is able to fit into the lock, CD4, which allows HIV to infect helper T cells. Other proteins on the surface of helper T cells, such as CCR5 and CXCR4, are also important for HIV infection and permit the virus to enter the cells, like a molecular doorknob.

Once in the cell, the HIV particles break down, releasing its viral genome and proteins. It then copies and pastes its genome into the cell’s genome and co-opts the cell’s own proteins to make more HIV particles. These particles are released into the bloodstream to infect more cells. These steps are discrete and involve the participation of both HIV and human proteins; one can imagine how interrupting anyone step can prevent the production of HIV particles.

In fact, this idea of blocking intermediate steps is how the first HIV antiretroviral therapies (ARTs) were initially conceived during the 1980s and 90s. Now, these drug therapies are often used in combination to control HIV viral levels in patients and prevent the transmission of HIV to romantic partners and healthcare workers. Despite incredible improvements in patient survival and quality of life, patients experience a lifetime of drug side effects, including liver toxicity and neuropathy, and these multi-drug regimens are by no means a cure — until now.

Last week, physicians and researchers in the United Kingdom reported that a patient had been “cured” of HIV, the second such report in the history of HIV. The patient, who is only identified as the “London” patient, was diagnosed with HIV in 2003, which was managed well with ART. In 2012, the patient was sadly diagnosed with advanced Hodgkin’s lymphoma, a rare blood cancer that affects white blood cells called lymphocytes, and received a special bone marrow transplant (BMT) as part of his treatment.

So what is BMT? All blood cells in the body—erythrocytes (red blood cells), macrophages, B lymphocytes, and T lymphocytes, including T helper cells—are made in the bone marrow. In lymphoma, the bone marrow produces too many abnormal lymphocytes, so treating lymphoma involves eradicating these abnormal cells and their precursors. Unfortunately, our best treatments, chemotherapy and radiation therapy, are unable to distinguish between healthy cells and diseased cells, and healthy bone marrow cells are destroyed in the process. This would be analogous to trying to use a flamethrower to weed a garden. After clearing the bone marrow, BMT is often needed to help the body regenerate blood cells.

In this case, the London patient received a BMT from a donor who had a rare mutation in CCR5 (dubbed CCR5∆32) that prevents CCR5 from being produced. CCR5 is one of the helper T cell proteins that permits HIV infection, and individuals with this mutation have been found to be more resistant to HIV infection. 18 months after receiving this special BMT, the London patient was found to have undetectable HIV levels. Could BMT cure HIV?

These are incredible and promising findings, but BMT is not without its risks and complications. In addition to requiring daily immunosuppressants, which disrupts the immune system in a way similar to HIV/AIDS, the London patient experienced dangerous side effects, including grant-versus-host-disease, where cells produced by the donor’s bone marrow attack the body’s tissues. There is also insufficient evidence to suggest that such approaches are better than ART, which are the current standard of care.

In spite of these limitations, scientists, physicians and HIV patients alike are excited about the prospect of using BMT to “cure” HIV. Perhaps in the coming decade, society as a whole will recognize the human experience of HIV patients and celebrate the spirit of its survivors.

Share on

  • Facebook
  • Twitter
  • Pinterest
  • Google +
  • LinkedIn
  • Email
Previous article“Your path is your path”: Mary Lou Akai Ferguson ’16 talks education, campaigning
Next articlePre-Med or Pre-Dread? The state of medical school applicants at Wellesley

You may also like

Professor Phillip Levine Discusses “A Problem of Fit”

CS Department shifts CS 111 course structure

WAMI and WRJ host discussion on criminalization of abortion

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Email Newsletter

Sign up to receive our weekly digest in your inbox

* indicates required

Top Articles

Sorry. No data so far.

Recent Tweets

Tweets by @Wellesley_News

The independent student newspaper of Wellesley College since 1901.

Sign up to receive our weekly digest in your inbox

* indicates required

  • About
  • Editorial Board
    • Staff Writers
  • Advertise
  • Join Us
  • Archives
COPYRIGHT © 2023 THE WELLESLEY NEWS
Back to top